Work

First-in-class YAP/TEAD Inhibitor Shows Promise in Hippo-driven Mesothelioma

Year: 2025

Type: article

Study design: Clinical Trial

Source: Cancer Discovery

DOI: 10.1158/2159-8290.cd-rw2025-107

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7116723915

FWCI: 0.431

Cites:

Cited by: 1

Related to: